Hepatitis viral markers in patients undergoing primary liver transplants

Jessica H. Lewis*, Lobna El-Ashmawy, Glenn E. Ramsey, Franklin A. Bontempo, Maya Rochlani, Anthony J. Demetris, David H. Van Thiel, Thomas E. Starzl

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The purpose of the study was to determine the prevalence in liver transplant (OLTx) patients of the hepatitis markers (anti-A, anti-B, anti-C, anti-D and HBsAg) and the interrelationships between markers and patients' sexes, ages, dates of transplant, clinicopathological diagnoses, and short-term survivals. Slightly more than half of the patients were male. Anti-A and anti-B were about evenly distributed between male and female. Anti-C, anti-D, and HBsAg were far more common in males. Age and year of transplant showed only a moderate increase in anti-A with increasing age. Anti-A was found in 57% of all patients, anti-B in 18%, anti-C in 17%, and HBsAg in 17%. Anti-D was tested only in patients who were positive for anti-B or HBsAg and occurred in 21 (11%) of 185. The poorest short-term survival occurred in males who showed both anti-A and HBsAg.

Original languageEnglish (US)
Pages (from-to)457-461
Number of pages5
JournalDigestive diseases and sciences
Issue number3
StatePublished - Mar 1993


  • anti-HAV
  • anti-HBV
  • anti-HCV
  • anti-HDV
  • hepatitis B surface antigen
  • hepatitis viruses
  • liver transplants

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Hepatitis viral markers in patients undergoing primary liver transplants'. Together they form a unique fingerprint.

Cite this